Seer (SEER) EBT Margin Growth (1y) (2021 - 2026)
Seer (SEER) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Seer |
99.67 Mn |
99.67 Mn |
982,000.00 |
-13,048.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-13,048.00 |
| Dec 31, 2025 |
16,105.00 |
| Sep 30, 2025 |
8,709.00 |
| Jun 30, 2025 |
26,551.00 |
| Mar 31, 2025 |
20,248.00 |
| Dec 31, 2024 |
-206,309.00 |
| Sep 30, 2024 |
-2,229.00 |
| Jun 30, 2024 |
-15,921.00 |
| Mar 31, 2024 |
-8,332.00 |
| Dec 31, 2023 |
201,113.00 |
| Sep 30, 2023 |
9,964.00 |
| Jun 30, 2023 |
4,547.00 |
| Mar 31, 2023 |
12,281.00 |
| Dec 31, 2022 |
15,466.00 |
| Sep 30, 2022 |
24,681.00 |
| Jun 30, 2022 |
61,550.00 |
| Mar 31, 2022 |
2.58 Mn |
| Dec 31, 2021 |
320,352.00 |
| Sep 30, 2021 |
1.06 Mn |
| Jun 30, 2021 |
736,992.00 |
